|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...3132333435363738394041...110111» |
- | Trial completion: Feasibility Study for Robotic Endomicroscopy to Better Define Resection Strategies (PERSEE) (clinicaltrials.gov) - Feb 11, 2016
P=N/A, N=30, Completed, Sponsor: Institut Mutualiste Montsouris
Recruiting --> Completed
- Trial primary completion date: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer (clinicaltrials.gov) - Feb 11, 2016
P2, N=12, Terminated, Sponsor: Gynecologic Oncology Group
Recruiting --> Completed Trial primary completion date: Jan 2007 --> Mar 2010
- docetaxel / Generic mfg.
Enrollment change, Metastases: Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer (clinicaltrials.gov) - Feb 11, 2016
P1, N=13, Completed, Sponsor: Gynecologic Oncology Group
Trial primary completion date: Jan 2007 --> Mar 2010 N=30 --> 13
- doxycycline / Generic mfg.
New trial: Efficacy of Dead Sea Peloid Gel in Chronic Endometritis (clinicaltrials.gov) - Feb 11, 2016
P=N/A, N=30, Completed, Sponsor: Scientific Center for Family Health and Human Reproduction Problems, Russia
- New trial: CHOiCE: Self-sampling for Non-participants in an Organised Cervical Cancer Screening Programme (clinicaltrials.gov) - Feb 11, 2016
P=N/A, N=9327, Not yet recruiting, Sponsor: University of Aarhus
- New trial: KCCPAS: Pilot Study of a Mobile Health Approach to Reduce Barriers to Cervical Cancer Screening in Tanzania (clinicaltrials.gov) - Feb 11, 2016
P=N/A, N=600, Recruiting, Sponsor: Queen's University
- carboplatin / Generic mfg., paclitaxel / Generic mfg.
Phase classification, Trial primary completion date: Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants (clinicaltrials.gov) - Feb 11, 2016
P1/2, N=27, Completed, Sponsor: Jeanne Drisko, MD, CNS, FACN
N=30 --> 13 Phase classification: P=N/A --> P1/2 | Trial primary completion date: Jul 2013 --> Aug 2007
- Trial primary completion date: Safety of Antioxidants During GYN Cancer Care (clinicaltrials.gov) - Feb 10, 2016
P2, N=25, Completed, Sponsor: Jeanne Drisko, MD, CNS, FACN
Phase classification: P=N/A --> P1/2 | Trial primary completion date: Jul 2013 --> Aug 2007 Trial primary completion date: Dec 2013 --> Dec 2006
- Votrient (pazopanib) / Novartis, BeiGene
Trial completion, Enrollment change: Phase I/II Study of Pazopanib and Cyclophosphamide in Patients With Platinum-resistant Recurrent Ovarian Cancer (clinicaltrials.gov) - Feb 10, 2016
P1/2, N=10, Completed, Sponsor: Priv.-Doz. Dr. med. Joachim Rom
Trial primary completion date: Dec 2013 --> Dec 2006 Active, not recruiting --> Completed | N=57 --> 10
- rilotumumab (AMG 102) / Amgen
Trial completion, Enrollment change, Trial primary completion date: Rilotumumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer (clinicaltrials.gov) - Feb 10, 2016
P2, N=31, Completed, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Completed | N=57 --> 10 Active, not recruiting --> Completed | N=50 --> 31 | Trial primary completion date: Jan 2100 --> Jul 2012
- Trial completion, Trial primary completion date, IO biomarker: Effect of Bacterial Vaginosis on HIV Susceptibility and Female Genital Immunology (clinicaltrials.gov) - Feb 10, 2016
P1, N=50, Completed, Sponsor: University of Toronto
Active, not recruiting --> Completed | N=50 --> 31 | Trial primary completion date: Jan 2100 --> Jul 2012 Recruiting --> Completed | Trial primary completion date: Mar 2016 --> Nov 2015
- Trial primary completion date: Simple Versus Radical Hysterectomy for Stage I Cervical Cancer (clinicaltrials.gov) - Feb 9, 2016
P=N/A, N=96, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Recruiting --> Completed | Trial primary completion date: Mar 2016 --> Nov 2015 Trial primary completion date: Jan 2017 --> Jan 2018
- Avastin (bevacizumab) / Roche
Enrollment closed, Enrollment change, Trial primary completion date: Autologous OC-DC Vaccine in Ovarian Cancer (clinicaltrials.gov) - Feb 9, 2016
P0, N=67, Active, not recruiting, Sponsor: Abramson Cancer Center of the University of Pennsylvania
Trial primary completion date: Jan 2017 --> Jan 2018 Recruiting --> Active, not recruiting | N=15 --> 67 | Trial primary completion date: May 2017 --> Jul 2015
- Trial completion, Trial primary completion date: Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2) (clinicaltrials.gov) - Feb 9, 2016
P1/2, N=12, Completed, Sponsor: University Health Network, Toronto
Recruiting --> Active, not recruiting | N=15 --> 67 | Trial primary completion date: May 2017 --> Jul 2015 Active, not recruiting --> Completed | Trial primary completion date: Jun 2015 --> Jun 2014
- celecoxib oral / Generic mfg.
Trial completion, Enrollment change, Metastases: Celebrex - Cervix: Celecoxib in the Treatment of Patients With Locally Advanced Carcinoma of the Cervix (clinicaltrials.gov) - Feb 9, 2016
P1/2, N=31, Completed, Sponsor: University Health Network, Toronto
Active, not recruiting --> Completed | Trial primary completion date: Jun 2015 --> Jun 2014 Active, not recruiting --> Completed | N=45 --> 31
- Enrollment open, Trial primary completion date: Evaluation of the Role of Follicular Sensitivity Index in the Prediction of IVF/ICSI Outcome (clinicaltrials.gov) - Feb 9, 2016
P=N/A, N=10000, Recruiting, Sponsor: Cairo University
Active, not recruiting --> Completed | N=45 --> 31 Active, not recruiting --> Recruiting | Trial primary completion date: Feb 2016 --> Feb 2017
- ||| azithromycin / Generic mfg.
Enrollment closed, Phase classification, Trial primary completion date: RESCUE: Drug Use Investigation Of Azithromycin IV For Community-Acquired Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan) (clinicaltrials.gov) - Feb 9, 2016
P4, N=400, Active, not recruiting, Sponsor: Pfizer
Active, not recruiting --> Recruiting | Trial primary completion date: Feb 2016 --> Feb 2017 Completed --> Active, not recruiting | Phase classification: PN/A --> P4 | Trial primary completion date: Nov 2015 --> May 2016
- ||| HSV vaccine (GEN-003) / Genocea, Shionogi
Enrollment closed, Enrollment change: Evaluating New Formulation of Therapeutic HSV-2 Vaccine (clinicaltrials.gov) - Feb 9, 2016
P2, N=135, Active, not recruiting, Sponsor: Genocea Biosciences, Inc.
Completed --> Active, not recruiting | Phase classification: PN/A --> P4 | Trial primary completion date: Nov 2015 --> May 2016 Recruiting --> Active, not recruiting | N=90 --> 135
- | docetaxel / Generic mfg.
Trial completion, Metastases: Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer (clinicaltrials.gov) - Feb 9, 2016
P1, N=13, Completed, Sponsor: Gynecologic Oncology Group
Recruiting --> Active, not recruiting | N=90 --> 135 Active, not recruiting --> Completed
- ||||| Lynparza (olaparib) / Merck (MSD), AstraZeneca
Trial initiation date, Trial primary completion date, Monotherapy, BRCA Biomarker, PARP Biomarker: Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes Mutations (clinicaltrials.gov) - Feb 9, 2016
P3, N=167, Not yet recruiting, Sponsor: AstraZeneca
Active, not recruiting --> Completed Initiation date: Apr 2016 --> Jul 2016 | Trial primary completion date: Jan 2019 --> Jun 2019
- Trial completion, Enrollment change: Frozen Embryo Donation Study (clinicaltrials.gov) - Feb 5, 2016
P=N/A, N=3568, Completed, Sponsor: Boston IVF
Initiation date: Apr 2016 --> Jul 2016 | Trial primary completion date: Jan 2019 --> Jun 2019 Active, not recruiting --> Completed | N=1200 --> 3568
- buparlisib (AN2025) / Novartis, Adlai Nortye
Enrollment change, Trial withdrawal, Metastases: Phase II, Open Label, Non-randomized, Trial of BKM120 for Metastatic or Locally Advanced Cervical Cancer (clinicaltrials.gov) - Feb 4, 2016
P2, N=0, Withdrawn, Sponsor: Novartis Pharmaceuticals
Active, not recruiting --> Completed | N=1200 --> 3568 N=29 --> 0 | Not yet recruiting --> Withdrawn
- | seribantumab (MM-121) / Elevation Oncology
Trial completion, Combination therapy, Metastases: A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers (clinicaltrials.gov) - Feb 4, 2016
P1, N=24, Completed, Sponsor: Merrimack Pharmaceuticals
N=29 --> 0 | Not yet recruiting --> Withdrawn Active, not recruiting --> Completed
- Trial primary completion date: Salivary Diagnostic Testing for IVF (clinicaltrials.gov) - Feb 4, 2016
P=N/A, N=1000, Enrolling by invitation, Sponsor: Boston IVF
Active, not recruiting --> Completed Trial primary completion date: Dec 2015 --> Dec 2018
- Trial primary completion date: Clinical Tests to Predict the Success of Assisted Reproductive Techniques (clinicaltrials.gov) - Feb 4, 2016
P=N/A, N=600, Recruiting, Sponsor: Martin Blomberg Jensen
Trial primary completion date: Dec 2015 --> Dec 2018 Trial primary completion date: Apr 2016 --> Jan 2017
- Prolia (denosumab) / Amgen, Daiichi Sankyo
Enrollment closed: TNFSF11 Inhibition and Fertility: a Prospective Study (clinicaltrials.gov) - Feb 4, 2016
P2, N=15, Active, not recruiting, Sponsor: Martin Blomberg Jensen
Trial primary completion date: Apr 2016 --> Jan 2017 Recruiting --> Active, not recruiting
- Trial completion, Trial primary completion date, HEOR: Robot-assisted Laparoscopic Hysterectomy-RALH- Postoperative Complications, Quality of Life and Health Economics (clinicaltrials.gov) - Feb 4, 2016
P=N/A, N=139, Completed, Sponsor: Copenhagen University Hospital at Herlev
Recruiting --> Active, not recruiting Active, not recruiting --> Completed | Trial primary completion date: Jan 2015 --> Feb 2016
- | Elonva (corifollitropin alfa) / Organon
Enrollment open, Trial initiation date, Trial primary completion date: OSSIE: Ovarian Stimulation Single Injection Elonva (clinicaltrials.gov) - Feb 3, 2016
P3, N=20, Recruiting, Sponsor: Flinders Fertility
Active, not recruiting --> Completed | Trial primary completion date: Jan 2015 --> Feb 2016 Not yet recruiting --> Recruiting | Initiation date: May 2015 --> Feb 2016 | Trial primary completion date: Oct 2015 --> Oct 2016
- || Trial primary completion date: Combining LHu With Ultrasound Monitoring in IUI (clinicaltrials.gov) - Feb 3, 2016
P=N/A, N=500, Recruiting, Sponsor: OVO R & D
Not yet recruiting --> Recruiting | Initiation date: May 2015 --> Feb 2016 | Trial primary completion date: Oct 2015 --> Oct 2016 Trial primary completion date: Jan 2016 --> Dec 2017
- New trial: Circadian Variation in Serum-progesterone Levels Following Controlled Ovarian Hyperstimulation. (clinicaltrials.gov) - Feb 3, 2016
P=N/A, N=10, Recruiting, Sponsor: Regionshospitalet Viborg, Skive
- || Trial primary completion date, HEOR: Health-Related Symptom Questionnaires in Measuring Quality of Life in HIV-Infected Participants Treated or Monitored for Anal Lesions (clinicaltrials.gov) - Feb 3, 2016
P=N/A, N=80, Recruiting, Sponsor: AIDS Malignancy Consortium
Trial primary completion date: Jan 2016 --> Dec 2017 Trial primary completion date: Dec 2015 --> Aug 2016
- Phase classification, PD(L)-1 Biomarker, IO biomarker, Gene therapy: T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers (clinicaltrials.gov) - Feb 3, 2016
P2, N=61, Recruiting, Sponsor: National Cancer Institute (NCI)
Trial primary completion date: Dec 2015 --> Aug 2016 Phase classification: P1/2 --> P2
- Enrollment closed: Vaginal vs. Laparoscopic Hysterectomy (clinicaltrials.gov) - Feb 3, 2016
P=N/A, N=100, Active, not recruiting, Sponsor: Medical University of Graz
Phase classification: P1/2 --> P2 Recruiting --> Active, not recruiting
- Trial completion, Surgery: Laparoscopy vs. Robotic Surgery for Endometriosis (LAROSE): a Prospective Randomized Controlled Trial (clinicaltrials.gov) - Feb 3, 2016
P=N/A, N=75, Completed, Sponsor: The Cleveland Clinic
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Menopur (menotropin) / Ferring
Trial primary completion date: HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients (clinicaltrials.gov) - Feb 2, 2016
P4, N=150, Recruiting, Sponsor: Mansoura University
Active, not recruiting --> Completed Trial primary completion date: Aug 2015 --> Feb 2016
- clomifene citrate / Generic mfg.
Preclinical, Trial initiation date: IVF Versus Gonadotropin Therapy in Women With CC Resistant PCOS (clinicaltrials.gov) - Feb 2, 2016
P4, N=100, Not yet recruiting, Sponsor: Mohamed Sayed Abdelhafez
Trial primary completion date: Aug 2015 --> Feb 2016 Initiation date: May 2015 --> Jan 2016
- clomifene citrate / Generic mfg.
Preclinical, Trial initiation date: IVF Versus LOD in Women With CC Resistant PCOS (clinicaltrials.gov) - Feb 2, 2016
P4, N=100, Not yet recruiting, Sponsor: Mohamed Sayed Abdelhafez
Initiation date: May 2015 --> Jan 2016 Initiation date: May 2015 --> Jan 2016
- ||||| New P2 trial: A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy (clinicaltrials.gov) - Feb 2, 2016
P2, N=200, Not yet recruiting, Sponsor: Warner Chilcott
- anastrozole/levonorgestrel (BAY 98-7196) / Bayer
Enrollment closed: Effect of Concomitant Use of an Antimycotic, an Antibiotic, a Spermicide or Tampons on Pharmacokinetics of Anastrozole and Levonorgestrel Released From Intra-vaginal Ring (clinicaltrials.gov) - Feb 2, 2016
P1, N=47, Active, not recruiting, Sponsor: Bayer
Initiation date: May 2015 --> Jan 2016 Recruiting --> Active, not recruiting
- New trial, Surgery: Antimullerian Hormone in Endometriomas (clinicaltrials.gov) - Feb 1, 2016
P=N/A, N=40, Not yet recruiting, Sponsor: Hospital Universitari de Bellvitge
- | letrozole / Generic mfg.
New P4 trial, Preclinical: Preventive Application of Letrozole Decrease Incidence of Early Onset of OHSS (clinicaltrials.gov) - Feb 1, 2016
P4, N=100, Completed, Sponsor: First Affiliated Hospital, Sun Yat-Sen University
- | Imfinzi (durvalumab) / AstraZeneca
New P2 trial: MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors (clinicaltrials.gov) - Feb 1, 2016
P2, N=136, Not yet recruiting, Sponsor: Washington University School of Medicine
- ||| Trial completion: Mirena Observational Program (clinicaltrials.gov) - Jan 30, 2016
P=N/A, N=2680, Completed, Sponsor: Bayer
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Trial primary completion date: Assessing the Disintegration, Safety, and Acceptability of Placebo Vaginal Inserts for the Delivery of Vaginal Products (clinicaltrials.gov) - Jan 29, 2016
P=N/A, N=50, Recruiting, Sponsor: CONRAD
Active, not recruiting --> Completed Trial primary completion date: Dec 2015 --> Mar 2016
- New trial: PET-MRI for Functional Imaging of the Testis: A Feasibility Study (clinicaltrials.gov) - Jan 29, 2016
P=N/A, N=20, Not yet recruiting, Sponsor: New York University School of Medicine
- New trial: ISOTOVE: Study of the Isotopic Distribution of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Ovarian Origin (clinicaltrials.gov) - Jan 29, 2016
P=N/A, N=20, Not yet recruiting, Sponsor: Centre Jean Perrin
- drospirenone/ethinyl estradiol / Generic mfg., rosiglitazone / Generic mfg.
Trial completion, Trial primary completion date: Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study (clinicaltrials.gov) - Jan 29, 2016
P4, N=65, Completed, Sponsor: Children's Hospital of Pittsburgh
Trial primary completion date: Dec 2015 --> Mar 2016 Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> Jul 2015
- | Trial completion, Trial primary completion date: Impact of Opportunistic Salpingectomy on Ovarian Reserve in Patients Undergoing Laparoscopic Hysterectomy (clinicaltrials.gov) - Jan 28, 2016
P3, N=68, Completed, Sponsor: CHA University
Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> Jul 2015 Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Jul 2015
- Trial completion: Prevention of Ovarian Cancer in Women Participating in Mammography (clinicaltrials.gov) - Jan 28, 2016
P=N/A, N=458, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Jul 2015 Active, not recruiting --> Completed
- Trial primary completion date: Multi-factorial Analysis of the Follicular Fluid Milieu to Explore the Discrepant Effect of Follicular Fluid Endometrial Flushing on Outcome of Assisted Reproduction Trial (clinicaltrials.gov) - Jan 28, 2016
P2/3, N=80, Recruiting, Sponsor: Benha University
Active, not recruiting --> Completed Trial primary completion date: Dec 2015 --> Jun 2016